Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 11 - 20 of 191 items for :

  • "papillary carcinoma" x
  • Refine by access: All content x
Clear All
E Saggiorato
Search for other papers by E Saggiorato in
Google Scholar
PubMed Close
,
R De Pompa
Search for other papers by R De Pompa in
Google Scholar
PubMed Close
,
M Volante
Search for other papers by M Volante in
Google Scholar
PubMed Close
,
S Cappia
Search for other papers by S Cappia in
Google Scholar
PubMed Close
,
F Arecco
Search for other papers by F Arecco in
Google Scholar
PubMed Close
,
A P Dei Tos
Search for other papers by A P Dei Tos in
Google Scholar
PubMed Close
,
F Orlandi
Search for other papers by F Orlandi in
Google Scholar
PubMed Close
, and
M Papotti
Search for other papers by M Papotti in
Google Scholar
PubMed Close

( Baloch et al. 2002 , Castro & Gharib 2003 ). Moreover, the cytological diagnosis of a follicular variant of papillary carcinoma represents an additional problem, since the diagnostic cytological criteria of papillary carcinoma (cytoplasmic

Article Type:
Research Article
DOI:
https://doi.org/10.1677/erc.1.00944
Volume/Issue:
Volume 12: Issue 2
Free access
Isabel Amendoeira Department of Pathology, Centro Hospitalar S. João, Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal
Ipatimup – Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal

Search for other papers by Isabel Amendoeira in
Google Scholar
PubMed Close
,
Tiago Maia Department of Pathology, Centro Hospitalar S. João, Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal

Search for other papers by Tiago Maia in
Google Scholar
PubMed Close
, and
Manuel Sobrinho-Simões Department of Pathology, Centro Hospitalar S. João, Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal
Ipatimup – Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
I3S – Institute of Investigation and Innovation in Health, Porto, Portugal

Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed Close

, follicular adenoma (FA) or follicular carcinoma (FTC) for encapsulated follicular-patterned lesions, the latter if capsular and/or vascular invasion was present, and papillary carcinomas for tumors displaying papillae formation. Later, Lindsay first ( Lindsay

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-17-0513
Volume/Issue:
Volume 25: Issue 4
Free access
Maria Rosaria Rusciano Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Maria Rosaria Rusciano in
Google Scholar
PubMed Close
,
Marcella Salzano Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Marcella Salzano in
Google Scholar
PubMed Close
,
Sara Monaco Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Sara Monaco in
Google Scholar
PubMed Close
,
Maria Rosaria Sapio Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Maria Rosaria Sapio in
Google Scholar
PubMed Close
,
Maddalena Illario Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Maddalena Illario in
Google Scholar
PubMed Close
,
Valentina De Falco Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Valentina De Falco in
Google Scholar
PubMed Close
,
Massimo Santoro Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Massimo Santoro in
Google Scholar
PubMed Close
,
Pietro Campiglia Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Pietro Campiglia in
Google Scholar
PubMed Close
,
Lucio Pastore Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy
Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Lucio Pastore in
Google Scholar
PubMed Close
,
Gianfranco Fenzi Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Gianfranco Fenzi in
Google Scholar
PubMed Close
,
Guido Rossi Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy
Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Guido Rossi in
Google Scholar
PubMed Close
, and
Mario Vitale Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy
Department of Biologia e Patologia Cellulare e Molecolare, Department of Endocrinologia ed Oncologia Molecolare e Clinica, Department of Scienze Farmaceutiche, Department of Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, CISI, Facoltà di Medicina, Università Federico II, Naples, Italy

Search for other papers by Mario Vitale in
Google Scholar
PubMed Close

experiment, single individual cultures were used. The TAD-2 cell line, obtained by Simian virus 40 infection of human fetal thyroid cells. was generously donated by Dr T F Davies (Mount Sinai, New York, NY, USA). Thyroid papillary carcinoma cell lines TPC-1

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-09-0214
Volume/Issue:
Volume 17: Issue 1
Free access
N Garcia de la Torre
Search for other papers by N Garcia de la Torre in
Google Scholar
PubMed Close
,
I Buley
Search for other papers by I Buley in
Google Scholar
PubMed Close
,
J A H Wass
Search for other papers by J A H Wass in
Google Scholar
PubMed Close
, and
H E Turner
Search for other papers by H E Turner in
Google Scholar
PubMed Close

), diffuse Hy due to Graves’ disease (22), follicular adenoma (FA) (54), papillary carcinoma (PC) (27), PMC (8), follicular carcinoma (FC) (20), MC (8) and normal thyroid (NT) tissue (19). Samples of NT tissue came from patients with a previous

Article Type:
Research Article
DOI:
https://doi.org/10.1677/erc.1.01210
Volume/Issue:
Volume 13: Issue 3
Free access
J M Gómez
Search for other papers by J M Gómez in
Google Scholar
PubMed Close
,
N Gómez
Search for other papers by N Gómez in
Google Scholar
PubMed Close
,
M Sahún
Search for other papers by M Sahún in
Google Scholar
PubMed Close
,
A Rafecas
Search for other papers by A Rafecas in
Google Scholar
PubMed Close
,
C Villabona
Search for other papers by C Villabona in
Google Scholar
PubMed Close
, and
J Soler
Search for other papers by J Soler in
Google Scholar
PubMed Close

Abstract

Despite the usual excellent prognosis of differentiated thyroid carcinoma, some patients die because of disease. It has been speculated that lethal disease may have a better prognosis if patients are treated with extensive surgery plus 131I ablative treatment. We have analyzed a group of 223 patients with differentiated thyroid carcinoma treated under a uniform therapeutic protocol of surgery and followed for 3 to 17.7 years, in order to differentiate patients with a high and a low risk of mortality and the influence of therapy on survival rate.

The therapeutic protocol was as follows. If the diagnosis was papillary carcinoma, subtotal thyroidectomy was performed and cervical nodes were removed if they were suspicious for cancer. If the diagnosis was follicular carcinoma, a total thyroidectomy was performed. 131I was given in cases of patients who were more than 60 years old or who had extrathyroid disease or metastases in papillary carcinomas and in macroangioinvasive follicular carcinomas. In survival analysis, the event used as the end-point was death due to thyroid carcinoma and summarized by the Kaplan-Meier curve and the Mantel-Cox method.

We found three independent prognostic factors which determined mortality: over 60 years of age, tumor size larger than 6 cm and metastases. On the basis of these factors we identified two risk groups: a low-risk group (A), who had no risk factors, composed of 153 patients whose survival rate at 205 months was 100% and a high-risk group (B), who had one or more risk factors, composed of 55 patients whose survival rate at 213 months was 39.6%. Seventeen patients in this second group died from thyroid carcinoma. We therefore analyzed the effect of treatment in group B. Patients who had more extensive surgery had a similar survival rate to those who had less extensive surgery and 131I administration did not modify the survival rate.

These data support the idea that the identification of low-risk groups may facilitate a more rational approach to treatment of differentiated thyroid carcinoma, avoiding aggressive therapy in cases with a good prognosis.

Endocrine-Related Cancer (1997) 4 459-464

Article Type:
Research Article
DOI:
https://doi.org/10.1677/erc.0.0404459
Volume/Issue:
Volume 4: Issue 4
Restricted access
Raffaele Ciampi
Search for other papers by Raffaele Ciampi in
Google Scholar
PubMed Close
,
Thomas J Giordano
Search for other papers by Thomas J Giordano in
Google Scholar
PubMed Close
,
Kathryn Wikenheiser-Brokamp
Search for other papers by Kathryn Wikenheiser-Brokamp in
Google Scholar
PubMed Close
,
Ronald J Koenig
Search for other papers by Ronald J Koenig in
Google Scholar
PubMed Close
, and
Yuri E Nikiforov
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed Close

pathway have been demonstrated to be crucial in the pathogenesis of papillary carcinomas, as they are found in more than 70% of all tumors and rarely overlap in the same tumor, suggesting that activation of a single effector of this pathway is sufficient

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-07-0039
Volume/Issue:
Volume 14: Issue 2
Free access
Monica Fedele Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy
Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Monica Fedele in
Google Scholar
PubMed Close
,
Dario Palmieri Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Dario Palmieri in
Google Scholar
PubMed Close
,
Gennaro Chiappetta Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Gennaro Chiappetta in
Google Scholar
PubMed Close
,
Rosa Pasquinelli Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Rosa Pasquinelli in
Google Scholar
PubMed Close
,
Ivana De Martino Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Ivana De Martino in
Google Scholar
PubMed Close
,
Claudio Arra Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Claudio Arra in
Google Scholar
PubMed Close
,
Giuseppe Palma Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Giuseppe Palma in
Google Scholar
PubMed Close
,
Teresa Valentino Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Teresa Valentino in
Google Scholar
PubMed Close
,
Giovanna M Pierantoni Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Giovanna M Pierantoni in
Google Scholar
PubMed Close
,
Giuseppe Viglietto Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Giuseppe Viglietto in
Google Scholar
PubMed Close
,
Jay L Rothstein Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Jay L Rothstein in
Google Scholar
PubMed Close
,
Massimo Santoro Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Massimo Santoro in
Google Scholar
PubMed Close
, and
Alfredo Fusco Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy
Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy
Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto dei Tumori di Napoli Fondazione ‘G. Pascale’, Dipartimento di Medicina Sperimentale e Clinica, Inflammation Research, NOGEC (Naples Oncogenomic Center)-Ceinge, Via S. Pansini 5, 80131 Naples, Italy

Search for other papers by Alfredo Fusco in
Google Scholar
PubMed Close

.4% of tumors ( Vasko et al . 2003 ). K-RAS mutations in exon 1 were found more often in papillary carcinomas ( De Micco 2003 ). The genetic lesions described above are mutually exclusive, since no tumors have been found bearing more than one of these

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-08-0272
Volume/Issue:
Volume 16: Issue 2
Free access
J Di Cristofaro
Search for other papers by J Di Cristofaro in
Google Scholar
PubMed Close
,
V Vasko
Search for other papers by V Vasko in
Google Scholar
PubMed Close
,
V Savchenko
Search for other papers by V Savchenko in
Google Scholar
PubMed Close
,
S Cherenko
Search for other papers by S Cherenko in
Google Scholar
PubMed Close
,
A Larin
Search for other papers by A Larin in
Google Scholar
PubMed Close
,
M D Ringel
Search for other papers by M D Ringel in
Google Scholar
PubMed Close
,
M Saji
Search for other papers by M Saji in
Google Scholar
PubMed Close
,
M Marcy
Search for other papers by M Marcy in
Google Scholar
PubMed Close
,
J F Henry
Search for other papers by J F Henry in
Google Scholar
PubMed Close
,
P Carayon
Search for other papers by P Carayon in
Google Scholar
PubMed Close
, and
C De Micco
Search for other papers by C De Micco in
Google Scholar
PubMed Close

heterogeneous tumor class and that some are composed of cell populations with different molecular oncogenic processes ( Ishizaka et al. 1991 , Vasko et al. 2003 ). In thyroid nodules with incomplete morphological features of papillary carcinoma, ret

Article Type:
Research Article
DOI:
https://doi.org/10.1677/erc.1.00884
Volume/Issue:
Volume 12: Issue 1
Free access
Sonia Cheng Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4
Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Sonia Cheng in
Google Scholar
PubMed Close
,
Wei Liu Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Wei Liu in
Google Scholar
PubMed Close
,
Moises Mercado Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Moises Mercado in
Google Scholar
PubMed Close
,
Shereen Ezzat Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Shereen Ezzat in
Google Scholar
PubMed Close
, and
Sylvia L Asa Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Sylvia L Asa in
Google Scholar
PubMed Close

metastatic sample; 45% were Stage T1, 56.8% were classified as papillary (including micropapillary), and 37.71% were follicular variant papillary carcinoma. Clinical and pathological variables From the 375 patients with complete clinical and pathologic

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-09-0002
Volume/Issue:
Volume 16: Issue 2
Free access
Dolly Thomas Department of Medicine, Department of Molecular, The Leon D. Black Family Stem Cell Institute, Mount Sinai School of Medicine, Box 1055, One Gustave L. Levy Place, New York, New York 10029, USA

Search for other papers by Dolly Thomas in
Google Scholar
PubMed Close
,
Susan Friedman Department of Medicine, Department of Molecular, The Leon D. Black Family Stem Cell Institute, Mount Sinai School of Medicine, Box 1055, One Gustave L. Levy Place, New York, New York 10029, USA

Search for other papers by Susan Friedman in
Google Scholar
PubMed Close
, and
Reigh-Yi Lin Department of Medicine, Department of Molecular, The Leon D. Black Family Stem Cell Institute, Mount Sinai School of Medicine, Box 1055, One Gustave L. Levy Place, New York, New York 10029, USA
Department of Medicine, Department of Molecular, The Leon D. Black Family Stem Cell Institute, Mount Sinai School of Medicine, Box 1055, One Gustave L. Levy Place, New York, New York 10029, USA
Department of Medicine, Department of Molecular, The Leon D. Black Family Stem Cell Institute, Mount Sinai School of Medicine, Box 1055, One Gustave L. Levy Place, New York, New York 10029, USA
Department of Medicine, Department of Molecular, The Leon D. Black Family Stem Cell Institute, Mount Sinai School of Medicine, Box 1055, One Gustave L. Levy Place, New York, New York 10029, USA

Search for other papers by Reigh-Yi Lin in
Google Scholar
PubMed Close

existence of stem-like cells in the adult thyroid. This view is shared by Burstein et al . (2004) who proposed a role for p63 in a stem cell model of papillary carcinoma. p63 has been detected via immunohistochemistry in basal and parabasal squamous cells

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-07-0210
Volume/Issue:
Volume 15: Issue 1
Free access